Intended Use:

Agdia has two positive control options for a CMV II positive control. One option is a lyophilized tissue control, LPC 44800. The other is a lyophilzed synthetic control, CPC 44800.

The tissue positive control for CMV II is a lyophilized positive control derived from naturally infected tissue and manufactured to serve as a positive control with our CMV II ELISA.

The synthetic positive control for CMV II is a synthetically produced material, not derived from plant tissue, designed to specifically react with antibodies used in our CMV II ELISA. This control is not recommended for use in molecular applications.

Includes:

• Vial of lyophilized control material.
• Makes 2 mL final solution.
• User Guide